First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Tissue Engineering

This is a "connection" page, showing publications Karl-Erik Andersson has written about Tissue Engineering.
Connection Strength

1.192
  1. Williams JK, Andersson KE. Regenerative pharmacology: recent developments and future perspectives. Regen Med. 2016 12; 11(8):859-870.
    View in: PubMed
    Score: 0.335
  2. Andersson KE. Words of wisdom. Re: Tissue engineering of the bladder: reality or myth? A systematic review. Eur Urol. 2014 Sep; 66(3):593.
    View in: PubMed
    Score: 0.287
  3. Salemi S, Tremp M, Plock JA, Andersson KE, Gobet R, Sulser T, Eberli D. Differentiated adipose-derived stem cells for bladder bioengineering. Scand J Urol. 2015; 49(5):407-14.
    View in: PubMed
    Score: 0.074
  4. Andersson KE. Potential of stem cell treatment in detrusor dysfunction. Adv Drug Deliv Rev. 2015 Mar; 82-83:117-22.
    View in: PubMed
    Score: 0.072
  5. Kim J, Andersson KE, Jackson JD, Lee SJ, Atala A, Yoo JJ. Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering. Tissue Eng Part A. 2014 Aug; 20(15-16):2265-72.
    View in: PubMed
    Score: 0.071
  6. Christ GJ, Saul JM, Furth ME, Andersson KE. The pharmacology of regenerative medicine. Pharmacol Rev. 2013 Jul; 65(3):1091-133.
    View in: PubMed
    Score: 0.066
  7. Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ. The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials. 2013 Apr; 34(13):3246-55.
    View in: PubMed
    Score: 0.064
  8. Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, Zhang Y. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011 Aug; 17(15-16):2123-32.
    View in: PubMed
    Score: 0.058
  9. Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180(5):2226-33.
    View in: PubMed
    Score: 0.047
  10. Andersson KE, Christ GJ. Regenerative pharmacology: the future is now. Mol Interv. 2007 Apr; 7(2):79-86.
    View in: PubMed
    Score: 0.043
  11. Christ G, Andersson KE, Atala A. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering. Curr Urol Rep. 2007 Mar; 8(2):95-9.
    View in: PubMed
    Score: 0.043
  12. Glindtvad C, Chen M, Vinge Nygaard J, Wogensen L, Forman A, Danielsen CC, Taskin MB, Andersson KE, Axelsen SM. Electrospun biodegradable microfibers induce new collagen formation in a rat abdominal wall defect model: A possible treatment for pelvic floor repair? . 2018 02; 106(2):680-688.
    View in: PubMed
    Score: 0.021
  13. Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.